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Abstract
Background. Fragility fractures, associated with osteoporosis,
are an escalating public health problem. We aim to describe sam-
ple selection, recruitment methods and reasons for non-participa-
tion in The PRedictors and Outcomes of incident FRACtures
(PROFRAC) study. 
Design and Methods. Barwon Statistical Division residents
aged 20+ years, with a radiologically-confirmed fracture between
June 1st 2012 and May 31st 2013, were eligible. Individuals iden-
tified as fracture cases were invited by mail to complete a ques-
tionnaire. Reasons for non-participation were documented.
Logistic regression techniques were used to determine odds ratios
for participation and non-participation reasons. 
Results. A total of 1,458 of 2,155 (67.7%) adults with fracture
(48.7% men) participated. Individuals were excluded due to
inability to give informed consent, death, no knowledge of frac-
ture, or inability to be contacted. The odds of participation
decreased with age (OR 0.99, 95%CI 0.99-0.99, P=0.011) and
increased among specific fracture groups [clavicle/scapula (OR
2.50, 1.30-4.68, P=0.006), forearm/humerus (OR 2.00, 1.22-3.27,
P=0.006), wrist (OR 2.08, 1.31-3.32, P=0.002), hip (OR 2.12,
1.20-3.75, P=0.009), ankle (OR 1.85, 1.20-2.87, P=0.001), com-
pared to face/skull fractures]. The odds of reporting disinterest,
time constraints or personal reasons as the reason for non-partici-
pation decreased with age, whereas the odds of reporting frailty,
language-related issues or illness as the reason for non-participa-
tion increased with of age [disinterest (OR 0.98, 0.97-0.98,
P<0.001), time constraints (OR 0.97, 0.96-0.98, P<0.001), person-
al reasons (OR 0.98, 0.97-0.99, P=0.007), frailty (OR 1.12, 1.09-
1.15, P<0.001), language-related issues (OR 1.02, 1.01-1.04,
P<0.001), illness (OR 1.03, 1.02-1.05, P<0.001)].
Conclusions. Understanding drivers of research participation can
inform study design to achieve optimal participation in health research.
Introduction
Osteoporosis is a common health issue in older adults.
Fragility fractures associated with osteoporosis are a major public
health problem among both men and women and are responsible
for considerable morbidity.1,2 It has been estimated fragility frac-
tures account for 0.83% of the global burden of non-communica-
ble disease.3 Fragility fractures are an escalating problem world-
wide,3,4 for example, in Australia, hip fractures alone, are predict-
ed to increase from 15.2 thousand per year (in 1996) to 60 thou-
sand per year by 2051.5 Loss of health-related quality of life asso-
ciated with low to moderate energy fracture can persist for 12-18
months post-fracture,6 thus identifying predictors and conse-
quences of incident fracture are imperative to identify modifiable
risk factors and reduce disease burden.  One of the major obstacles
to producing good quality research is participant recruitment.
Studies with poor recruitment strategies are at risk of non-partici-
pant/selection bias and lack of generalizability, which are impor-
tant for valid epidemiological research.7 Investigators have been
known to try a variety of recruitment strategies including mass-
media/advertising, direct mail out, face-to-face recruitment,
mixed modes of data collection, referrals and incentives with
varying results.7-11 Monetary or prize draw incentives are reported
to increase the rate of recruitment substantially;12 however, this
can be unmanageable due to catchment area variance, budgetary
constraints and/or ethical, institution- or country-specific restric-
tions.7,11,13 Targeted mail outs are generally cost-effective and are
a time-efficient method for successful recruitment,8 and follow-up
contact such as reminder letters or emails have been shown to
increase recruitment rates further.11 Other factors, such as ques-
tionnaire length, notification prior to mail out and personalised
questionnaires may also increase recruitment rates.12 To improve
recruitment for health studies, researchers have called for trans-
parency in recruitment methods and it has been acknowledged that
shared experience can inform recruitment strategies and help
reduce associated burden.10,11,13,14 With these data in mind, the
PRedictors and Outcomes of incident FRACtures (PROFRAC)
study has been designed to capture valuable information from a
robust source using cost effective methods of recruitment within a
strict budget and protocol. Thus, the aim of this paper is to
describe sample selection, recruitment methods and reasons for
non-participation in the PROFRAC study.
Significance for public health
Fragility fractures associated with osteoporosis are a major public health
concern for our aging population. Identifying predictors and consequences
of incident fracture is thus imperative if we are to target modifiable risk fac-
tors and reduce the burden of disease. This manuscript describes sample
selection, cost-effective recruitment methods and reasons for non-participa-
tion for the PRedictors and Outcomes of incident FRACtures (PROFRAC)
study. Understanding drivers of research participation and barriers to partic-
ipation is necessary to inform study design to achieve optimal participation
in comprehensive samples.
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Design and Methods
Study design
PROFRAC is a case-control study designed to examine predic-
tors and consequences of incident fracture in men and women,
including lifestyle factors (smoking, physical activity, diet, alco-
hol), social determinants (education, income, occupation, and
housing circumstances) and existing medical co-morbidities and
medication usage. The study utilises data from men and women
who had sustained an incident fracture (fracture cases) and the
Geelong Osteoporosis Study (GOS) participants who had no histo-
ry of adult fracture (non-fracture controls). This manuscript
describes the participation of fracture cases only, further details
regarding sampling, recruitment, methodology and outcomes of
the GOS are published elsewhere.9
Study region
Cases and controls were recruited from the Barwon Statistical
Division (BSD), a geographically well-defined region of south-
eastern Australia. The region is included within the
Commonwealth Electoral Rolls for Corio, Lalor and Corangamite.
It is considered to be well suited to epidemiological research as it
has a defined population consisting of a range of social, cultural
and geographical settings, with a centralised health provider (the
University Hospital Geelong) located in Geelong. Approximately
235,000 adults (20 years plus) were residing in the region at June
30, 2010.15 The region is similar in age distribution, country of
birth, education, marital status, employment and income profiles to
the Australian population, allowing data from this sample to be
extrapolated to national levels.9,16
Sample selection
Fracture cases 
All residents of the BSD, aged 20 years and older, with at least
one fracture at any skeletal site between June 1st 2012 and May 31st
2013 were invited to participate in the current study. Fractures
were identified by a daily computerised keyword search of all
University Hospital Geelong (Barwon Health) radiological reports.
Reports referring to “possible” fracture were not included unless
radiologically confirmed at a later date. This method of fracture
ascertainment has been previously validated and utilised to docu-
ment fracture epidemiology in the region.17,18 Exclusion criteria
included fractures with a pathological origin and/or inability to
provide written informed consent. Residents of the catchment area
who sustained a subsequent fracture during the study period were
invited to participate for the first fracture only. Date and site of
subsequent fractures were recorded; however, these participants
were not required to complete a second questionnaire. Fracture site
was identified and pooled according to body region: 1) face/skull;
2) vertebra; 3) ribs; 4) clavicle/scapula; 5) pelvis; 6)
forearm/humerus; 7) wrist; 8) hand/fingers/thumb; 9) hip; 10)
femur/patella/tibia/fibula; 11) ankle; and 12) foot/toes. Individuals
with multiple fractures from the same event were grouped under
multiple fractures. At the end of each month, potential participants
were sent a letter of invitation to participate in the study along with
the participant information and consent form, reply-paid envelope
and the study questionnaire. In conjunction with the mail out, lists
of outpatient clinic attendees and hospital ward patients were
screened for identified fracture cases, and participation in the study
was discussed with these individuals in person during their visit to
the hospital. Participants who did not respond by the end of the
month were followed up by telephone contact at varying times dur-
ing work and non-work hours, including weekends. In addition, a
second letter of invitation was sent if contact was not able to be
made via telephone. A variety of strategies was employed to
encourage participation: advertisements detailing the study design
were displayed in the University Hospital Geelong’s Imaging
Department, and on noticeboards throughout the hospital and
media coverage by the local newspapers. Hospital staff at the out-
patient clinic and wards in which fracture patients were hospi-
talised were also educated on the study aims and protocol and
encouraged to promote the study to eligible persons.
The reason for declining participation was documented and
grouped according to the following themes: 1) disinterest (not
interested/cannot be bothered/does not want to); 2) frailty (old age/
inability to cope with involvement in the study/inability to under-
stand the study due to age); 3) illness (illness associated with frac-
ture/cancer/other illness); 4) time constraints (work commit-
ments/home commitments/too busy); 5) language-related issues;
6) personal reasons (invasion of privacy/religious or philosophical
reasons/personal reasons/dissatisfaction with medical
services/already completed another survey); and 7) undeter-
minable reason (no reason given). Study refusals returned by mail
were usually accompanied by a note from the invited person
describing the reason for non-participation or were otherwise clas-
sified as undeterminable.
Socioeconomic status (SES)
For each eligible PROFRAC participant, the full residential
address was electronically matched to the corresponding
Australian Bureau of Statistics (ABS) 2011 census data. ABS ref-
erence data were used to determine the Socio-Economic Index For
Areas (SEIFA) value from ABS 2011 census data for each partici-
pant.19 SEIFA indices summarise the characteristics of participants
within an area, and provide a single measure to rank the level of
advantage and disadvantage at the area level. The Index of
Relative Socio-economic Advantage and Disadvantage (IRSAD)
score, which accounts for socioeconomic parameters including
income and type of occupation, was employed for this study; a low
score as measured by the IRSAD indicates, relative to other areas,
the most disadvantaged area, while a high score indicates the most
advantaged area.19 In 2011, approximately 4% of census areas
could not be given a SEIFA score due to low population density in
areas, or poor data quality.19 SEIFA values were unavailable for 95
(4.4%) of the 2,155 eligible patients and were thus excluded from
this analysis. Validation of the SEIFA indexes have been undertak-
en by ABS analysts, combined with an external peer review of
methodology used in SEIFA 2011.20
Study integrity
Approval to conduct the study was received from the Barwon
Health and Deakin University Human Research Ethics
Committees. Written informed consent was obtained from all par-
ticipants. Due to ethical constraints, the only data available for
non-participants were reason for non-participation, age, sex, area-
based SES and fracture type and date.
Statistical analyses
Descriptive data are presented, whereby median and interquar-
tile range are provided for continuous non-parametric variables
and number (percentage) were employed for categorical variables.
The Pearson’s chi-square test was used to examine differences
between participants and non-participants with regards to categor-
ical variables, and Kruskal-Wallis for non-parametric continuous
variables. Binary logistic regression models were used to deter-
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mine the odds ratio (OR) and 95% confidence intervals (95% CI)
for i) likelihood of agreeing to participate and ii) non-participation
reason. Backwards elimination techniques were employed to deter-
mine best models. Statistical analyses were performed using
Minitab (version 16; Minitab, State College, PA).
Results
A total of 3,027 men and women with fracture who presented
to the University Hospital Geelong were invited to participate in
PROFRAC. Of these, 153 had died, 193 were unable to give
informed consent due to cognitive impairment, 451 were unable to
be contacted and 75 were unaware of having a fracture. Of the
remaining 2,155 (47.6% men) men and women, 697 declined par-
ticipation for the following reasons: disinterest (44.5%), frailty
(15.1%), illness (7.1%), time constraints (12.7%), language-related
issues (8.6%), personal reasons (10.5%) and undeterminable rea-
son (1.5%). A total of 1,458 men and women (48.7% men) agreed
to participate in the study (response 67.7% of eligible participants:
68.5% for men, 66.9% for women). Table 1 presents differences
between participants and non-participants according to sex, age,
SES and skeletal site of fracture and the corresponding participa-
tion rate. There was no difference in the proportion of men (48.7%)
and women (51.3%) who participated in the study. However, non-
participants were older and a higher proportion were in the most
disadvantaged SES group. Non-participants had a higher propor-
tion of face/skull and vertebral fractures and participants had a
higher proportion of ankle fractures. Low participation rates were
evident among those with rib and hand/fingers/thumb fractures,
whereas high participation rates were evident for clavicle/scapula,
forearm/humerus and wrist fractures, however the difference
between participants and non-participants at these sites were not
significant.
The odds of participation decreased with age (OR 0.99, 95%CI
0.99-0.99, P=0.011) and increased among specific fracture groups
[clavicle/scapula OR 2.50 95%CI 1.30-4.68, P=0.006,
forearm/humerus OR 2.00, 95%CI 1.22-3.27, P=0.006, wrist OR
2.08, 95%CI 1.31-3.32, P=0.002, hip OR 2.12, 95%CI 1.20-3.75,
P=0.009, ankle OR 1.85, 95%CI 1.20-2.87, P=0.001, compared to
face/skull fractures]. SES and sex did not affect these results. 
The odds of reporting disinterest, or personal reasons as the
reason for non-participation decreased with age, whereas the odds
of reporting frailty or illness as the reason for non-participation
increased with of age (Table 2). The odds of reporting time con-
straints as the reason for non-participation decreased with age and
was increased among higher SES quintiles. Whereas the odds of
reporting language-related issues as the reason for non-participa-
tion increased with age and decreased incrementally with each
quintile of SES. Small numbers prevented further investigation
into the drivers behind reporting an undetermined reason for non-
participation.
                                Article
Table 1. Participation rate and differences in characteristics between participants and non-participants.
Group                                                 Participation rate,      All fracture patients,        Participants          Non-participants          P value
                                                                         %                                n=2155                        n=1458                      n=697                         
Sex, male                                                                            68.5                                      1026 (48.0)                            703 (48.7)                          323 (46.5)                           0.42
Age at fracture                                                                                                                                                                                                                                                             
      20-29 years                                                                   68.1                                       310 (14.4)                             211 (14.5)                           99 (14.2)                            0.02
      30-39 years                                                                   70.0                                       270 (12.5)                             189 (13.0)                           81 (11.6)                               
      40-49 years                                                                   68.9                                       280 (13.0)                             193 (13.2)                           87 (12.5)                               
      50-59 years                                                                   70.4                                       321 (14.9)                             226 (15.5)                           95 (13.6)                               
      60-69 years                                                                   72.0                                       349 (16.1)                             249 (17.1)                           97 (13.9)                               
      70-79 years                                                                   64.2                                       282 (13.1)                             181 (12.4)                          101 (14.5)                              
      80+ years                                                                     60.4                                       346 (16.1)                             209 (14.3)                          137 (19.7)                              
Age at fracture, Continuous, years                                 -                                       57.5, 38.4-73.4                       56.6, 38.2-71.3                    59.0, 39.2-77.1                        0.02
Socioeconomic status                                                                                                                                                                                                                                                
      Quintile 1 (most disadvantaged)                           62.6                                       463 (22.5)                             290 (20.9)                          173 (25.9)                           0.02
      Quintile 2                                                                     66.0                                       412 (20.0)                             272 (19.6)                          140 (20.9)                              
      Quintile 3                                                                     68.3                                       590 (28.6)                             403 (29.0)                          187 (28.0)                              
      Quintile 4                                                                     70.0                                       387 (18.8)                             271 (19.5)                          116 (17.3)                              
      Quintile 5                                                                     74.5                                       208 (10.1)                             155 (11.1)                            53 (7.9)                                 
Fracture site (% single fracture only)                                                                                                                                                                                                                   
      Face/skull                                                                     55.4                                         92 (4.6)                                 51 (3.8)                              41 (6.4)                             0.01
      Vertebra                                                                       59.9                                        177 (8.9)                               106 (7.8)                            71 (11.0)                            0.02
      Rib                                                                                 59.6                                        104 (5.2)                                62 (4.6)                              42 (6.5)                             0.07
      Clavicle/scapula                                                          75.8                                         66 (3.3)                                 50 (3.7)                              16 (2.5)                             0.16
      Pelvis                                                                             61.4                                         44 (2.2)                                 27 (2.0)                              17 (2.6)                             0.35
      Forearm/ humerus                                                    72.3                                       213 (10.7)                             154 (11.4)                            59 (9.2)                             0.14
      Wrist                                                                             72.3                                       318 (15.9)                             230 (17.0)                           88 (13.7)                            0.06
      Hand/fingers/thumb                                                  63.0                                       273 (13.7)                             172 (12.7)                          101 (15.7)                           0.07
      Hip                                                                                 69.5                                        118 (5.9)                                82 (6.1)                              36 (5.6)                             0.69
      Femur/patella/tibia/fibula                                         69.6                                        135 (6.8)                                94 (6.9)                              41 (6.4)                             0.64
      Ankle                                                                             74.8                                       202 (10.1)                             151 (11.1)                            51 (7.9)                             0.03
      Foot/ toes                                                                    68.9                                       257 (12.9)                             177 (13.1)                           80 (12.4)                            0.70
Multiple fractures                                                            65.4                                        156 (7.2)                               102 (7.0)                             54 (7.8)                             0.53
Results presented as percent (%), median, interquartile range or n (%). Missing data: SES n=95, Fracture site n=156 (multiple fractures).
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Discussion
This study reports a participation of 67.7% amongst eligible
participants. The most frequent reason for non-participation was
disinterest, followed by frailty, time constraints, personal reasons,
language-related issues, illness, and then undeterminable reasons.
Age was a major factor in the reason for non-participation, increas-
ing the odds of reporting frailty, language-related issues and illness
but decreasing the odds of reporting disinterest, time constraints
and personal reasons. Overall, participation was influenced by age
and fracture site. Interestingly, there was no difference in the over-
all number of male and female participants. 
Studies utilising individuals from the same region have also
yielded good recruitment and retention when utilising similar
recruitment strategies such as direct mail outs.8,9 Previously, a
cohort of fracture patients, aged 35 and older, were recruited from
the same region reporting a participation rate of 77%.21 Similarly,
the Geelong Osteoporosis Study reported a participation rate of
77% for the female cohort and 67% for the male cohort, although
participants were recruited from the population not on the basis of
fracture status.8,9
A Cochrane review by Edwards et al. has reported that both
monetary incentives and non-monetary incentives, shorter length
of questionnaire, hand written addresses, pre-notification, follow-
up contact and assurance of confidentiality all improve participa-
tion rates in health studies.12 Unfortunately, the number of partici-
pants and budget of the current study prevented hand-writing
addresses on envelopes and using monetary incentives. Also, for
comprehensive investigation of risk factors and outcomes associat-
ed with fracture the amount of information collected for the current
study meant the length of questionnaire was rather long. However,
assurance of confidentiality, follow-up contact and pre-notification
of contact were all part of the protocol for the current study. The
pre-notification was in the form of advertisement posters displayed
throughout the hospital, local newspaper coverage and education
of hospital staff working with fracture patients. Home visits are
another possible avenue to improve participation however, bud-
getary constraints prevented this in our case. 
Akin to the Geelong Osteoporosis Study,10 being disinterested
was the most commonly cited reason for non-participation.
However, this has not been the most common reason for non-par-
ticipation in other studies. An investigation into the Nord-
Trøndelag Health Study (HUNT 3) study, reported the most com-
mon reason for non-participation was lack of time or inconve-
nience, which was reported by 50.7% of non-participating women
and 56.6% of non-participating men.22 In contrast, lack of per-
ceived benefit, distrust and poor health were reported as the most
common reasons for non-participation amongst frail older adults in
a systematic review investigating challenges and strategies for
recruitment of the frail elderly.14 In this study, we identified that
the non-participants were older than the participants, however
there was still strong participation up until age 70. The elderly are
often under-represented in population-based studies and, given the
ageing population, this demographic should be targeted.23
Galea (2007) cited four main reasons for decreased participa-
tion in epidemiological studies over time: an increase in invitations
to other research projects, a decreased desire to volunteer in pro-
jects without direct personal benefit, diminishing enthusiasm to
science in general, and the increasing burden of time to the partic-
ipant. Aside from time constraints, which explained 13% of non-
participation in the current study, Galea’s reasons for non-partici-
pation may have been encompassed in our disinterested category.
Otmar and colleagues24 investigated cultural models of osteoporo-
sis in the same study region as the current study, and showed that
osteoporosis is considered to be of low salience in the community
which might explain the disinterest shown by some of the individ-
uals approached to participate in the study. Reporting of disinterest
for the reason for non-participation was influenced by age, where-
by younger adults were more likely to cite it. This is most likely
due to the public perception that fragility fracture, an outcome of
osteoporosis, is commonly thought to be associated with old age. 
Lack of understanding of the research process, importance of
research and health literacy have all been identified as potential
barriers to participation for patients in lower SES groups.25 The
HUNT 3 study found lower participation amongst the most disad-
vantaged group.23 Similarly, the lowest participation rate was seen
in the lowest SES group in the current study, however these partic-
ipants contributed to one-fifth of the overall participant group, thus
are still well represented. It has been consistently reported that
individuals from higher SES groups are more likely to participate
in research studies7,22 and our study is no exception. Surprisingly,
the highest participation rate seen in the highest SES group (quin-
tile 5) equates to only 11% of the overall group. The largest amount
of fractures occurred in the middle SES group (quintile 3) and thus
the greatest proportion of participants was from this group.
Although we found differences in SES quintiles between partici-
pants and non-participants in the unadjusted analyses, SES did not
remain in the final model with age and fracture type. Higher SES
was found to increase the odds of reporting time constraints and
decrease the odds of reporting language-related issues as the rea-
son for non-participation. 
Differences in participation by fracture site were observed;
notably, non-participants had a higher proportion of face/skull and
vertebral fractures. The lower number of participants with
face/skull and clinical vertebral fractures who participated in the
PROFRAC study may be indicative of the overall health of the
patient, or the cause of fracture. Road traffic accidents, assault and
falls are the most common causes of maxillofacial injuries,26 each
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Table 2. Logistic regression models for predicting reason for non-participation. Results are presented as odds ratio (OR) and 95% con-
fidence intervals (95%CI). 
                                              Disinterest           Frailty         Time constraints  Personal reasons   Language-related issues       Illness
Model 1   Age                                0.98 (0.97-0.98)*   1.12 (1.09-1.15)*       0.97 (0.96-0.98)*         0.98 (0.97-0.99)**                  1.02 (1.01-1.04)*             1.03 (1.02-1.05)*
Model 2   Age                                0.97 (0.96-0.98)*   1.12 (1.10-1.15)*       0.97 (0.96-0.98)*        0.99 (0.98-0.99)***                 1.02 (1.01-1.04)*             1.03 (1.02-1.05)*
                  SES
                  Quintile 1 (referent)              -                                -                                    -                                       -                                                -                                          -
                  Quintile 2                     0.82 (0.51-1.32)       1.44 (0.70-3.0)       2.83 (1.25-6.42)***         0.70 (0.33-1.47)                  0.40 (0.19-0.85)***        1.36 (0.60-3.09)***
                  Quintile 3                       1.4 (0.92-2.19)       1.17 (0.57-2.38)      2.29 (1.04-5.05)***         0.59 (0.29-1.20)                  0.34 (0.16-0.70)***        0.80 (0.34-1.88)***
                  Quintile 4                     0.81 (0.49-1.33)      1.04 (0.44-2.47)      4.47 (2.02-9.89)***         0.89 (0.42-1.85)                  0.29 (0.11-0.73)***        1.06 (0.41-2.72)***
                  Quintile 5                     0.77 (0.40-1.47)      1.69 (0.56-5.08)      3.48 (1.33-9.12)***         1.60 (0.67-3.67)                  0.11 (0.01-0.81)***        1.06 (0.41-2.72)***
*P<0.001, **P<0.01, ***P<0.05.
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of which have associated psychological distress that may impact
on the decision to participate in research. Bed rest and limited
movement associated with treatment for vertebral fractures,27 com-
bined with the resulting pain from the fracture may have decreased
the desire and/or ability to participate in research. However, we
note that this was not evident for participation among those with
hip fracture.
A large proportion of potential participants were excluded for
reasons including death, inability to give informed consent, no
knowledge of fracture and inability to be contacted. Risk of death
following fracture is increased immediately after fracture, and has
been shown to remain elevated for a decade following the frac-
ture,28,29 therefore a decline in number of eligible participants was
likely. The issue of the individual having no knowledge of the frac-
ture was difficult to tackle. It is beyond the scope of the role, as
researchers, to discuss results with patients, so it was decided a pri-
ori to exclude participants who were unaware of the presence of
fractures – these were largely clinical vertebral fractures. This
minor limitation is acknowledged, as unrecognised vertebral frac-
tures have been associated with impaired wellbeing and physical
function.30 Although an effort was made to contact patients during
non-work hours, including week nights and weekends, there were
451 patients who were coded as unable to be contacted. Tajeu
(2013) reported that patients with hip fracture were up to four-fold
more likely to require long-term nursing facility care compared
with matched comparators one year on, and Galea (2007) suggest-
ed that longer working hours make it difficult to contact partici-
pants. These factors may have contributed to the difficulty in locat-
ing some patients. 
Conclusions
This manuscript highlights characteristics of non-participants
in a large fracture sample that included sex, socio-economic fac-
tors, fracture site, sample selection and methods of recruitment.
Fracture site and age were the strongest predictors of non-partici-
pation and thus form the groups that require more intensive atten-
tion when recruiting. Understanding drivers of research participa-
tion is necessary to inform the design of studies to achieve optimal
participation in health research.
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